532331 Stock Overview
Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
Ajanta Pharma Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹2,131.40 |
| 52 Week High | ₹2,355.05 |
| 52 Week Low | ₹1,240.55 |
| Beta | 0.018 |
| 1 Month Change | -0.81% |
| 3 Month Change | -2.65% |
| 1 Year Change | 66.51% |
| 3 Year Change | 75.82% |
| 5 Year Change | 223.12% |
| Change since IPO | 13,221.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532331 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 3.2% | -0.5% | 1.4% |
| 1Y | 66.5% | 55.3% | 46.1% |
Return vs Industry: 532331 exceeded the Indian Pharmaceuticals industry which returned 55.3% over the past year.
Return vs Market: 532331 exceeded the Indian Market which returned 46.1% over the past year.
Price Volatility
| 532331 volatility | |
|---|---|
| 532331 Average Weekly Movement | 4.1% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 532331 has not had significant price volatility in the past 3 months.
Volatility Over Time: 532331's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 7,713 | Yogesh Agrawal | www.ajantapharma.com |
Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages. The company markets and serves various therapeutic segments, such as antimalarial, cardiology, ophthalmology, dermatology, pain management, gastroenterology, antihistamine, respiratory, diabetes areas. It also provides tablets, capsules, powder, liquid, jelly, ointments, sterile eye drops, active pharma ingredient.
Ajanta Pharma Limited Fundamentals Summary
| 532331 fundamental statistics | |
|---|---|
| Market cap | ₹268.24b |
| Earnings (TTM) | ₹7.36b |
| Revenue (TTM) | ₹40.36b |
36.5x
P/E Ratio6.7x
P/S RatioIs 532331 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532331 income statement (TTM) | |
|---|---|
| Revenue | ₹40.36b |
| Cost of Revenue | ₹11.03b |
| Gross Profit | ₹29.34b |
| Other Expenses | ₹21.98b |
| Earnings | ₹7.36b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 02, 2024
| Earnings per share (EPS) | 58.43 |
| Gross Margin | 72.68% |
| Net Profit Margin | 18.23% |
| Debt/Equity Ratio | 0.9% |
How did 532331 perform over the long term?
See historical performance and comparison